Javascript must be enabled to continue!
The 15-Year Shadow: Borderline Lepromatous Leprosy with Erythema Nodosum Leprosum Following Prolonged Treatment Default
View through CrossRef
Background: Leprosy, caused by Mycobacterium leprae, persists as a global health issue where the primary challenges are not merely microbial but are deeply rooted in delayed diagnosis and poor treatment adherence. These delays, often driven by profound social stigma, lead to progressive, irreversible disability and sustain community transmission. Erythema Nodosum Leprosum (ENL), an acute immunological complication, further devastates patients' quality of life and complicates management.
Case presentation: A 53-year-old Indonesian farmer presented with a 15-year history of untreated leprosy, a journey of neglect initiated by fear of treatment side effects and community ostracism. Clinical examination revealed advanced borderline lepromatous (BL) leprosy with diffuse skin infiltration, multiple anesthetic plaques, and thickened, tender peripheral nerves. He had established WHO Grade 1 disability, characterized by significant sensory loss in his hands and feet and early intrinsic muscle atrophy. A slit-skin smear confirmed a bacteriological index of +3 with a morphological index of 5%, indicating a high load of viable bacilli. Histopathology confirmed BL leprosy with a concurrent mild ENL reaction. A comprehensive, patient-centered management plan was initiated, including a 12-month course of multidrug therapy (MDT-MB), adjunctive care, and intensive counseling.
Conclusion: This case powerfully illustrates the "shadow effect" of leprosy—how years of untreated disease, fueled by psychosocial barriers, culminate in a complex nexus of advanced infection, immunological reaction, and permanent neurological impairment. The patient's successful re-engagement with the health system underscores that eradicating the burden of leprosy requires a paradigm shift from a purely pharmacological approach to a deeply humanistic one. Effective control hinges on building compassionate health systems that actively dismantle stigma, empower patients with knowledge, and deliver holistic, multidisciplinary care to prevent the profound human cost of neglect.
Title: The 15-Year Shadow: Borderline Lepromatous Leprosy with Erythema Nodosum Leprosum Following Prolonged Treatment Default
Description:
Background: Leprosy, caused by Mycobacterium leprae, persists as a global health issue where the primary challenges are not merely microbial but are deeply rooted in delayed diagnosis and poor treatment adherence.
These delays, often driven by profound social stigma, lead to progressive, irreversible disability and sustain community transmission.
Erythema Nodosum Leprosum (ENL), an acute immunological complication, further devastates patients' quality of life and complicates management.
Case presentation: A 53-year-old Indonesian farmer presented with a 15-year history of untreated leprosy, a journey of neglect initiated by fear of treatment side effects and community ostracism.
Clinical examination revealed advanced borderline lepromatous (BL) leprosy with diffuse skin infiltration, multiple anesthetic plaques, and thickened, tender peripheral nerves.
He had established WHO Grade 1 disability, characterized by significant sensory loss in his hands and feet and early intrinsic muscle atrophy.
A slit-skin smear confirmed a bacteriological index of +3 with a morphological index of 5%, indicating a high load of viable bacilli.
Histopathology confirmed BL leprosy with a concurrent mild ENL reaction.
A comprehensive, patient-centered management plan was initiated, including a 12-month course of multidrug therapy (MDT-MB), adjunctive care, and intensive counseling.
Conclusion: This case powerfully illustrates the "shadow effect" of leprosy—how years of untreated disease, fueled by psychosocial barriers, culminate in a complex nexus of advanced infection, immunological reaction, and permanent neurological impairment.
The patient's successful re-engagement with the health system underscores that eradicating the burden of leprosy requires a paradigm shift from a purely pharmacological approach to a deeply humanistic one.
Effective control hinges on building compassionate health systems that actively dismantle stigma, empower patients with knowledge, and deliver holistic, multidisciplinary care to prevent the profound human cost of neglect.
Related Results
Borderline Lepromatous Leprosy with Severe Erythema Nodosum Leprosum: A Case Report
Borderline Lepromatous Leprosy with Severe Erythema Nodosum Leprosum: A Case Report
Background: Leprosy is a chronic granulomatous infectious disease caused by Mycobacterium leprae (M. leprae) that primarily infects Schwann cells in the peripheral nerves, leading ...
Knowledge and self-care practice of leprosy patients at ALERT Hospital,
Ethiopia
Knowledge and self-care practice of leprosy patients at ALERT Hospital,
Ethiopia
Abstract
Background
Leprosy is a chronic infectious disease of public health importance and
one of ...
Morbus hansen tipe borderline lepromatous pada seorang anak dengan riwayat narakontak erat kusta tipe mulibasiler: laporan kasus
Morbus hansen tipe borderline lepromatous pada seorang anak dengan riwayat narakontak erat kusta tipe mulibasiler: laporan kasus
Background: Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae and Mycobaterium lepromatosis. Children are one of the populations at risk of M. leprae transm...
EVALUATION OF HISTOPATHOLOGICAL EXAMINATION OF SKIN BIOPSY IN DIAGNOSIS OF LEPROSY WITH CLINICAL CORRELATION
EVALUATION OF HISTOPATHOLOGICAL EXAMINATION OF SKIN BIOPSY IN DIAGNOSIS OF LEPROSY WITH CLINICAL CORRELATION
Background: Leprosy is a chronic granulomatous infection caused by M. leprae (also known as Hansen disease) predominantly affects the skin
and peripheral nerves. It is difcult to ...
Relationship Between Inflammatory Bowel Disease and Erythema Nodosum and Psoriasis: Using Mendelian Randomization
Relationship Between Inflammatory Bowel Disease and Erythema Nodosum and Psoriasis: Using Mendelian Randomization
Abstract
Background
Erythema nodosum and psoriasis are two prevalent extraintestinal manifestations of inflammatory bowel disease (IBD). Erythema nodosum usually appears b...
Epidemiological Characteristics and Factors Associated with Cure of Leprosy in Chongqing, China, from 1949 to 2019
Epidemiological Characteristics and Factors Associated with Cure of Leprosy in Chongqing, China, from 1949 to 2019
ABSTRACT.
Chongqing is one of the focuses of leprosy control in China. Although leprosy control in Chongqing has achieved remarkable results over the years, there are also some pro...
LEPROSY A CHANGE IN PROFILE?
LEPROSY A CHANGE IN PROFILE?
Leprosy has been ofcially eliminated from India since December, 2005; still there are districts and blocks reporting high prevalence indicating
ongoing transmission. Thepresent st...
Interaction between leprosy and HIV infection
Interaction between leprosy and HIV infection
Introduction: Leprosy and Human Immunodeficiency Virus (HIV) infections still count as major health issues worldwide. Starting with the HIV pandemic back in the eighties, leprosy w...

